Research Article

Role of Lactium™ in Psychodermatology: The CERTAIN Trial# on Patients with Acne Vulgaris

Table 4

Safety data.

Adverse eventsGroup A (Nixiyax plus standard of care) (N = 45)Group B (standard of care) (N = 40)Overall (N = 85)

Total number of AEs reported12 (26.67)09 (22.5)21 (24.70)
Subjects reporting at least one AE6 (13.33)5 (12.5)11 (12.94)
Total number of SAEs reported000
Number of deaths000

AEs, adverse events; SAEs, severe adverse events.